Table 3.

Operation-related outcomes

Characteristics	ArtiSential (n=40)
Total operation time (min), mean±SD	187.0±49.2
Endometrial cancer (n=19)	171.5±41.6
Cervical cancer (n=15)	268.1±54.5
Ovarian cancer (n=6)	247.0±44.2
Pelvic LN assessment, n (%)
Yes	34 (85.0)
No	6 (15.0)
Para-aortic LN assessment, n (%)
Yes	20 (50.0)
No	20 (50.0)
Use of ArtiSential during LN assessment (n=34), n (%)
Yes	22 (64.7)
No	12 (35.3)
LN assessment time (min), mean±SD	40.3±19.4
Pelvic LN yield (n), mean±SD	6.7±5.5
Omentectomy, n (%)
Yes	6 (15.0)
No	34 (85.0)
Use of ArtiSential during omentectomy, n (%)
Yes	2 (33.3)
No	4 (66.6)
Omentectomy time (min), mean±SD	16.3±11.8
Hb change (g/dL), mean±SD	1.57±1.23
Conversion to laparotomy, n (%)	0
Intraoperative complications, n (%)	0
Postoperative complications, n (%)
ALT elevation	1 (2.5)
Allergic urticaria	2 (5.0)

ALT: Aspartate aminotransferase, Hb: Hemoglobin, LN: Lymph node, SD: Standard deviation